Search

everythinglearnresearchcommunity

for

Search:↓

The Hairless gene is crucial for healthy skin and hair growth.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

Chitosan slows root hair growth and causes a buildup of callose at low concentrations, but at high concentrations, it only inhibits growth without callose buildup.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The study found potential new DNA patterns in fertility genes, but further testing is needed.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.